Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > REGULATORY
REGULATORY
- Only About 50% of Doctors Aware of ADR Relief System: PMDA
June 12, 2013
- Half of Patients Unaware of New Anticoagulants: Healthy Japan 21 Promotion Forum Survey
June 11, 2013
- Expert Subcommittee to Begin Discussions on Next Year’s NHI Price Revision on June 12
June 11, 2013
- Director Kamada of HPB’s Economic Affairs Division Calls for Cooperation in Promoting Distribution Reform
June 11, 2013
- Bill to Amend PAL Unlikely to Be Enacted in Current Diet Session
June 10, 2013
- MHLW to Establish “PMDA-WEST” in Kansai Region in October
June 10, 2013
- Council Announces “Comprehensive STI Strategy” to Create One Trillion Yen Market for Regenerative Medicine by 2030
June 10, 2013
- Japan Set to Perk Up R&D to Expand Drug Market to 9 Trillion Yen in 2020
June 7, 2013
- MHLW Asks Industry Organization to Take Steps to Ensure Proper COI Management in Response to Diovan Scandal: HPB Director-General at Diet
June 7, 2013
- Abe Vows to Lift Ban on Online OTC Drug Sales; MHLW to Form Panel to Verify Safety
June 6, 2013
- Novartis Pharma Taking Steps to “Clean Up Its Act” in Wake of Diovan Scandal: Minister of Health Tamura
June 5, 2013
- Study Group Fails to Reach Agreement on Online Sales of OTC Drugs; Final Report to Collate Different Views
June 4, 2013
- Provisional Measure Allowing Online Sales of Class 2 and 3 OTC Drugs to Be Extended to End of 2013: MHLW
June 4, 2013
- MHLW to Look into Correlations of Pediatric Drug Intakes and Adverse Reactions
June 3, 2013
- 14 APIs/26 Products Including Third Domestic Biosimilar Receive Listing
June 3, 2013
- FDA Approves World’s First MEK Inhibitor Discovered by JT
May 31, 2013
- Members of Study Group Say Ban on Use of Medical Information Database by Drug Makers Should Be Reconsidered After Trial Period Ends
May 31, 2013
- Expert Subcommittee to Begin Discussing Cost-Effective Assessments for Specific Medical Technologies
May 31, 2013
- H. pylori Eradication Could Greatly Reduce Medical Expenditure; Manufacturers of PPIs Will Need to Educate the Public
May 31, 2013
- Outline of Growth Strategy Embraces Japan-Version NIH, Promotion of Special System for Mixed Healthcare
May 30, 2013
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…